William Querbes

Alnylam Pharmaceuticals (United States)

Papers

1

Total Citations

200

H-Index

1

About

William Querbes has made transformative contributions to nanomedicine and intracellular delivery, pioneering high-throughput approaches to engineer nanoparticles for therapeutic applications. His landmark 2011 study, cited over 200 times, introduced a combinatorial synthesis strategy that generated 1,536 structurally distinct core-shell nanoparticles, systematically varying cationic cores and surface shells. This work functioned like an assembly line for nanocarrier discovery, revealing critical design rules for complexation, cellular internalization, and cargo delivery that were inaccessible through traditional one-by-one testing. Querbes' research bridges materials science and cell biology, enabling the rational design of nanoparticles for RNA therapeutics, gene editing, and vaccine delivery. His impact is evident in the widespread adoption of combinatorial nanoparticle libraries for drug delivery optimization, accelerating the translation of nucleic acid therapies from bench to bedside. By demonstrating that high-throughput screening can decode structure-activity relationships in nanocarriers, Querbes has fundamentally shifted how researchers approach intracellular delivery, making his work essential reading for anyone developing next-generation therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
200
Total Citations
200
Avg Citations/Paper
🏆 Most Cited Paper
Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery
200 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Alnylam Pharmaceuticals (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago